iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 93.0% in March

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 321 shares, a drop of 93.0% from the March 15th total of 4,568 shares. Based on an average trading volume of 635 shares, the short-interest ratio is currently 0.5 days. Approximately 0.2% of the shares of the company are short sold.

iShares Neuroscience and Healthcare ETF Price Performance

Shares of iShares Neuroscience and Healthcare ETF stock traded down $0.58 during trading hours on Friday, reaching $33.52. The company had a trading volume of 2,734 shares, compared to its average volume of 1,967. iShares Neuroscience and Healthcare ETF has a one year low of $18.91 and a one year high of $37.00. The business has a fifty day simple moving average of $32.09 and a 200 day simple moving average of $31.01. The firm has a market cap of $5.03 million, a PE ratio of 15.61 and a beta of 0.82.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.